Surgery Partners (NASDAQ:SGRY) Given “Overweight” Rating at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a research report released on Friday, Benzinga reports. Cantor Fitzgerald currently has a $43.00 price target on the stock.

A number of other equities analysts have also weighed in on the stock. Citigroup lowered their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a buy rating on the stock in a research report on Wednesday, August 7th. Royal Bank of Canada reaffirmed an outperform rating and issued a $49.00 target price on shares of Surgery Partners in a report on Wednesday, August 7th. StockNews.com cut shares of Surgery Partners from a hold rating to a sell rating in a report on Wednesday, August 7th. Benchmark reaffirmed a buy rating and issued a $50.00 price objective on shares of Surgery Partners in a report on Monday, August 26th. Finally, Macquarie started coverage on Surgery Partners in a research note on Friday, June 28th. They set an outperform rating and a $31.00 target price for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Surgery Partners currently has a consensus rating of Moderate Buy and an average target price of $39.86.

Surgery Partners Stock Down 3.4 %

SGRY stock opened at $30.11 on Friday. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96. Surgery Partners has a twelve month low of $22.05 and a twelve month high of $36.92. The company’s 50 day moving average is $30.81 and its two-hundred day moving average is $27.78. The stock has a market cap of $3.83 billion, a P/E ratio of 45.10, a PEG ratio of 2.45 and a beta of 2.75.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the firm posted $0.25 earnings per share. Research analysts expect that Surgery Partners will post 0.86 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. First Eagle Investment Management LLC raised its position in shares of Surgery Partners by 16.5% during the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock worth $10,127,000 after purchasing an additional 48,100 shares during the last quarter. Iron Triangle Partners LP acquired a new position in shares of Surgery Partners during the 4th quarter worth approximately $33,415,000. BNP Paribas Financial Markets raised its position in shares of Surgery Partners by 33.7% during the 1st quarter. BNP Paribas Financial Markets now owns 421,137 shares of the company’s stock worth $12,563,000 after purchasing an additional 106,054 shares during the last quarter. Bamco Inc. NY raised its position in shares of Surgery Partners by 100.0% in the first quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after buying an additional 45,000 shares during the last quarter. Finally, Lombard Odier Asset Management Europe Ltd purchased a new position in shares of Surgery Partners during the second quarter valued at approximately $4,163,000.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.